Omnimmune Holdings Stock Performance

OMMH Stock  USD 0.0001  0.00  0.00%   
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Omnimmune Holdings are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Omnimmune Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Omnimmune Holdings is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor
3:1
Last Split Date
2008-07-01
1
Argentinas Bonds, Stocks, Currency Rally After Milei Victory - The Wall Street Journal
10/27/2025

Omnimmune Holdings Relative Risk vs. Return Landscape

If you would invest  0.01  in Omnimmune Holdings on September 29, 2025 and sell it today you would earn a total of  0.00  from holding Omnimmune Holdings or generate 0.0% return on investment over 90 days. Omnimmune Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Omnimmune, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Omnimmune Holdings Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Omnimmune Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Omnimmune Holdings, and traders can use it to determine the average amount a Omnimmune Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
OMMH
Based on monthly moving average Omnimmune Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omnimmune Holdings by adding Omnimmune Holdings to a well-diversified portfolio.

Omnimmune Holdings Fundamentals Growth

Omnimmune Stock prices reflect investors' perceptions of the future prospects and financial health of Omnimmune Holdings, and Omnimmune Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omnimmune Stock performance.

About Omnimmune Holdings Performance

By evaluating Omnimmune Holdings' fundamental ratios, stakeholders can gain valuable insights into Omnimmune Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Omnimmune Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Omnimmune Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(64.44)(67.66)
Return On Capital Employed 0.31  0.57 
Return On Assets(64.44)(67.66)
Return On Equity 0.29  0.34 

Things to note about Omnimmune Holdings performance evaluation

Checking the ongoing alerts about Omnimmune Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omnimmune Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Omnimmune Holdings generated a negative expected return over the last 90 days
Omnimmune Holdings has some characteristics of a very speculative penny stock
Omnimmune Holdings currently holds 987.05 K in liabilities. Omnimmune Holdings has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Omnimmune Holdings' use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 0.
Omnimmune Holdings currently holds about 4.8 K in cash with (252.43 K) of positive cash flow from operations.
Omnimmune Holdings has a very weak financial position based on the latest SEC disclosures
Evaluating Omnimmune Holdings' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Omnimmune Holdings' stock performance include:
  • Analyzing Omnimmune Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omnimmune Holdings' stock is overvalued or undervalued compared to its peers.
  • Examining Omnimmune Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Omnimmune Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omnimmune Holdings' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Omnimmune Holdings' stock. These opinions can provide insight into Omnimmune Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Omnimmune Holdings' stock performance is not an exact science, and many factors can impact Omnimmune Holdings' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Omnimmune Stock analysis

When running Omnimmune Holdings' price analysis, check to measure Omnimmune Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnimmune Holdings is operating at the current time. Most of Omnimmune Holdings' value examination focuses on studying past and present price action to predict the probability of Omnimmune Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnimmune Holdings' price. Additionally, you may evaluate how the addition of Omnimmune Holdings to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins